You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 228 Engineered human IL-2/IL-2Rß orthogonal pairs selectively enhance anti-GPC3 CAR T cells in vivo to drive complete responses in solid epithelial tumor models

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
228 Engineered human IL-2/IL-2Rß orthogonal pairs selectively enhance anti-GPC3 CAR T cells in vivo to drive complete responses in solid epithelial tumor models

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023272022
Dec 20235707
Jan 20241402
Feb 20242402
Mar 20243803
Apr 20243003
May 20241000
Jun 20243804
Jul 20242502
Aug 20241806
Sep 20244605
Oct 20245205
Nov 20244209
Dec 202426012
Jan 20252804
Feb 2025005
Mar 2025005
Apr 2025003
May 2025004
Jun 2025002
Total7200105